论文部分内容阅读
肺癌易发生骨转移[1]。放射性核素骨显像比CT、X线片及MRI检测提早3~6个月发现骨转移病灶,是发现骨转移的首选检测方法[2]。随着分子生物学和免疫学的不断发展,血清肿瘤标志物在肿瘤的诊断、评价疗效和判断预后方面具有越来越重要的价值。现将我院2008年7月至2011年5月收治的115例资料完整的肺癌病例进行综合分析,报告如下。对象与方法1.一般资料:本组115例,均为原发性肺癌骨转移者,男69例,女46例;年龄43~88岁,平均61.58岁。其中腺癌30例,鳞癌46例,小细胞肺癌17例,其他病理类型癌22例。按骨显像结果分为:骨显像
Lung cancer prone to bone metastases [1]. Radionuclide bone imaging than CT, X-ray and MRI detection of bone metastases 3 to 6 months earlier, is the preferred detection of bone metastases [2]. With the continuous development of molecular biology and immunology, serum tumor markers have more and more important value in tumor diagnosis, evaluation of curative effect and judgment of prognosis. Now in our hospital from July 2008 to May 2011 admitted 115 cases of complete lung cancer data were analyzed as follows. Subjects and methods 1. General information: This group of 115 patients, all patients with primary bone metastasis of lung cancer, 69 males and 46 females; aged 43 to 88 years, mean 61.58 years. There were 30 cases of adenocarcinoma, 46 cases of squamous cell carcinoma, 17 cases of small cell lung cancer and 22 cases of other pathological types. Bone imaging results are divided into: bone imaging